Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
Back to Search Results

Connection

Search Results to Lisa Anne Bero

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Bero, Lisa

Item TypeName
Concept beta-Endorphin
Concept Vitamin D
Concept Nonprescription Drugs
Concept Vaccines
Concept Magnesium Sulfate
Concept 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
Concept Sweetening Agents
Concept Antipsychotic Agents
Concept Fluorocarbons
Concept Codeine
Concept Caprylates
Concept Receptors, Adrenergic, alpha
Concept Fluoxetine
Concept Angiogenesis Inhibitors
Concept Piperazines
Concept Insulin
Concept Receptors, Opioid, kappa
Concept Atrazine
Concept Calcium Channel Blockers
Concept Narcotics
Concept Calcium, Dietary
Concept Pharmaceutical Preparations
Concept DNA-Binding Proteins
Concept Enkephalin, D-Penicillamine (2,5)-
Concept Polyvinyls
Concept Morphine
Concept Nicotine
Concept Thyroxine
Concept Tocolytic Agents
Concept Methadone
Concept Environmental Pollutants
Concept Drugs, Investigational
Concept Prolactin
Concept Hydrazines
Concept Reserpine
Concept Receptors, Dopamine
Concept Pyrazoles
Concept Hypoglycemic Agents
Concept Cannabis
Concept Catecholamines
Concept Serotonin
Concept Antibodies, Monoclonal
Concept Receptors, Opioid
Concept 5,7-Dihydroxytryptamine
Concept Norepinephrine
Concept Hazardous Substances
Concept Cocaine
Concept Endorphins
Concept Alkaloids
Concept Hydroxyzine
Concept Food
Concept Amines
Concept Thiazolidinediones
Concept Pyrrolidines
Concept Peptide Fragments
Concept Cholesterol, LDL
Concept Growth Hormone
Concept Antineoplastic Agents
Concept Aspirin
Concept Calcium
Concept Sympatholytics
Concept Receptors, Serotonin
Concept Analgesics, Opioid
Concept Iodine Radioisotopes
Concept Cyclohexanecarboxylic Acids
Concept Propylamines
Concept Drugs, Essential
Concept Cyproheptadine
Concept Corticosterone
Concept Anticoagulants
Concept Alendronate
Concept Anticholesteremic Agents
Concept Analgesics
Concept Prescription Drugs
Concept Dynorphins
Concept Anticonvulsants
Concept Hydroxymethylglutaryl-CoA Reductase Inhibitors
Concept Carcinogens
Concept Propofol
Concept Endocrine Disruptors
Concept Triclosan
Concept gamma-Aminobutyric Acid
Concept Food Additives
Concept Antihypertensive Agents
Concept Thiadiazines
Concept Vinyl Chloride
Concept Polymethacrylic Acids
Concept Vitamins
Concept Enkephalins
Concept Hydroxyindoleacetic Acid
Concept Anti-Infective Agents, Local
Concept p-Chloroamphetamine
Concept Sodium, Dietary
Concept Dopamine
Concept Haloperidol
Concept Receptors, Opioid, mu
Concept Pyridones
Concept 5-Hydroxytryptophan
Concept Pravastatin
Concept Immunoglobulin Fab Fragments
Concept Antibodies, Monoclonal, Humanized
Academic Article Strategies for obtaining unpublished drug trial data: a qualitative interview study.
Academic Article The decision-making process of US Food and Drug Administration advisory committees on switches from prescription to over-the-counter status: a comparative case study.
Academic Article Medicine shortages in Fiji: A qualitative exploration of stakeholders' views.
Academic Article Essential medicines availability is still suboptimal in many countries: a scoping review.
Academic Article Priority medicines for maternal and child health: a global survey of national essential medicines lists.
Academic Article Availability, prices and affordability of the World Health Organization's essential medicines for children in Guatemala.
Academic Article Expensive medicines: ensuring objective appraisal and equitable access.
Academic Article To give is better than to receive: compliance with WHO guidelines for drug donations during 2000-2008.
Academic Article Perinatal effects of drugs of abuse.
Academic Article Association of trial registration with the results and conclusions of published trials of new oncology drugs.
Academic Article Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009.
Academic Article The Food and Drug Administration reports provided more data but were more difficult to use than the European Medicines Agency reports.
Academic Article Regulatory agencies hold the key to improving Cochrane reviews of drugs.
Academic Article On WHO's essential medicines process and transparency.
Academic Article Medical donations are not always free: an assessment of compliance of medicine and medical device donations with World Health Organization guidelines (2009-2017).
Academic Article Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns.
Academic Article Applying the essential medicines concept to US preferred drug lists.
Academic Article Review of the quality of pediatric medications in developing countries.
Grant Measuring Design, Reporting and Funding Bias in Nonclinical Research
Academic Article "There are ways ? drug companies will get into DTC decisions": How Australian drug and therapeutics committees address pharmaceutical industry influence.
Academic Article A critical review of methodologies used in pharmaceutical pricing policy analyses.

Search Criteria
  • Pharmaceutical Preparations

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)